LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 23 filers reported holding LANTERN PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,585 | -39.7% | 46,506 | -0.2% | 0.06% | -32.9% |
| Q2 2023 | $262,847 | -44.7% | 46,604 | -52.6% | 0.08% | +3.7% |
| Q1 2023 | $475,166 | +56.2% | 98,378 | +95.3% | 0.08% | -24.8% |
| Q4 2022 | $304,253 | +28.4% | 50,373 | +1.8% | 0.11% | +23.9% |
| Q3 2022 | $237,000 | -16.5% | 49,502 | -0.3% | 0.09% | -13.7% |
| Q2 2022 | $284,000 | -20.2% | 49,664 | -0.3% | 0.10% | -3.8% |
| Q1 2022 | $356,000 | -9.4% | 49,793 | +1.2% | 0.11% | -3.6% |
| Q4 2021 | $393,000 | -25.8% | 49,187 | +3.7% | 0.11% | -33.7% |
| Q3 2021 | $530,000 | -20.2% | 47,442 | +4.3% | 0.17% | -14.9% |
| Q2 2021 | $664,000 | -18.6% | 45,500 | +1.1% | 0.20% | -23.2% |
| Q1 2021 | $816,000 | – | 44,991 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |